Linking liver metabolic and vascular disease via bile acid signaling
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Linking liver metabolic and vascular disease via bile acid signaling
Authors
Keywords
bile acid, non-alcoholic fatty liver disease (NAFLD), cardiovascular disease, FXR, GPBAR1
Journal
TRENDS IN MOLECULAR MEDICINE
Volume 28, Issue 1, Pages 51-66
Publisher
Elsevier BV
Online
2021-11-21
DOI
10.1016/j.molmed.2021.10.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis
- (2021) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease
- (2021) Stefano Fiorucci et al. Expert Opinion on Drug Discovery
- Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy‐proven non‐alcoholic fatty liver disease
- (2021) Sonja Lang et al. LIVER INTERNATIONAL
- Targeting inflammation in atherosclerosis — from experimental insights to the clinic
- (2021) Oliver Soehnlein et al. NATURE REVIEWS DRUG DISCOVERY
- Bile acids and their receptors in metabolic disorders
- (2021) Stefano Fiorucci et al. PROGRESS IN LIPID RESEARCH
- Muricholic Acids Promote Resistance to Hypercholesterolemia in Cholesterol-Fed Mice
- (2021) Dany Gaillard et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Cilofexor, a Nonsteroidal FXR Agonist, in Non‐Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
- (2020) Keyur Patel et al. HEPATOLOGY
- Of mice and men: Murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism
- (2020) Sara Straniero et al. JOURNAL OF LIPID RESEARCH
- High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation
- (2020) Katharina Lechner et al. Metabolic Syndrome and Related Disorders
- Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)
- (2020) Stefano Fiorucci et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- L-Arginine-Nitric Oxide-Asymmetric Dimethylarginine Pathway and the Coronary Circulation: Translation of Basic Science Results to Clinical Practice
- (2020) Attila Cziráki et al. Frontiers in Pharmacology
- Systematic review and meta-analysis of randomized controlled trials on the effects of obeticholic acid on the blood lipid profile: Insights into liver disorders and liver cancer
- (2020) Lin Guan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy
- (2020) Adriana Carino et al. FASEB JOURNAL
- The Power of Plasticity—Metabolic Regulation of Hepatic Stellate Cells
- (2020) Parth Trivedi et al. Cell Metabolism
- Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
- (2020) Rohit Loomba et al. HEPATOLOGY
- Nonalcoholic Fatty Liver Disease and the Incidence of Myocardial Infarction: A Cohort Study
- (2019) Dong Hyun Sinn et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
- (2019) Paul J. Pockros et al. LIVER INTERNATIONAL
- Direct Amplification of Tissue Factor:Factor VIIa Procoagulant Activity by Bile Acids Drives Intrahepatic Coagulation
- (2019) Kevin S. Baker et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
- (2019) Myriam Alexander et al. BMJ-British Medical Journal
- Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
- (2019) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Bile acids in glucose metabolism in health and disease
- (2018) Hagit Shapiro et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- Future trends in the treatment of non-alcoholic steatohepatitis
- (2018) Stefano Fiorucci et al. PHARMACOLOGICAL RESEARCH
- Burden of Illness and Economic Model for Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States
- (2018) Zobair M. Younossi et al. HEPATOLOGY
- Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis
- (2018) Adriana Carino et al. FASEB JOURNAL
- Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption
- (2018) Young-Chae Kim et al. GASTROENTEROLOGY
- Homocysteine Modification in Protein Structure/Function and Human Disease
- (2018) Hieronim Jakubowski PHYSIOLOGICAL REVIEWS
- Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
- (2017) Harald Staiger et al. ENDOCRINE REVIEWS
- Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice
- (2017) Jan Freark de Boer et al. GASTROENTEROLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- Bi-directional analysis between fatty liver and cardiovascular disease risk factors
- (2017) Jiantao Ma et al. JOURNAL OF HEPATOLOGY
- Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance
- (2017) Manuel Lasalle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans
- (2017) Panu K. Luukkonen et al. THROMBOSIS AND HAEMOSTASIS
- BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis
- (2017) Adriana Carino et al. Scientific Reports
- Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis
- (2017) Sabrina Cipriani et al. Scientific Reports
- Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice
- (2017) Adriana Carino et al. Scientific Reports
- An Intestinal Farnesoid X Receptor–Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice
- (2016) Cen Xie et al. DIABETES
- Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?
- (2016) R. J. Hodge et al. DIABETES OBESITY & METABOLISM
- An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
- (2016) Frank J. Gonzalez et al. GASTROENTEROLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Preserved hemostatic status in patients with non-alcoholic fatty liver disease
- (2016) Wilma Potze et al. JOURNAL OF HEPATOLOGY
- Regulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted state
- (2016) Dandan Guan et al. Journal of Translational Medicine
- A new frontier in FGF21 biology
- (2016) Matthew J. Potthoff Nature Reviews Endocrinology
- Metabolic fibroblast growth factors (FGFs): Mediators of energy homeostasis
- (2016) Kathleen R. Markan et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Mechanism and Regulation of NLRP3 Inflammasome Activation
- (2016) Yuan He et al. TRENDS IN BIOCHEMICAL SCIENCES
- Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids
- (2015) Barbara Renga et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Nonalcoholic Fatty Liver Disease and Vascular Function: Cross-Sectional Analysis in the Framingham Heart Study
- (2015) M. T. Long et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Discovery of Intestinal Targeted TGR5 Agonists for the Treatment of Type 2 Diabetes
- (2015) Hongliang Duan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Leptin in nonalcoholic fatty liver disease: A narrative review
- (2015) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases
- (2015) Fangfang Zhang et al. MOLECULAR ENDOCRINOLOGY
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders
- (2015) Stefano Fiorucci et al. TRENDS IN MOLECULAR MEDICINE
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1
- (2015) Barbara Renga et al. PLoS One
- 4-Benzofuranyloxynicotinamide derivatives are novel potent and orally available TGR5 agonists
- (2014) Qingan Zou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
- (2014) Ffolliott M. Fisher et al. GASTROENTEROLOGY
- Procoagulant imbalance in patients with non-alcoholic fatty liver disease
- (2014) Armando Tripodi et al. JOURNAL OF HEPATOLOGY
- Design, Synthesis, and Biological Evaluation of Potent Dual Agonists of Nuclear and Membrane Bile Acid Receptors
- (2014) Claudio D’Amore et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploitation of Cholane Scaffold for the Discovery of Potent and Selective Farnesoid X Receptor (FXR) and G-Protein Coupled Bile Acid Receptor 1 (GP-BAR1) Ligands
- (2014) Carmen Festa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual Activation of the Bile Acid Nuclear Receptor FXR and G-Protein-Coupled Receptor TGR5 Protects Mice against Atherosclerosis
- (2014) Shinobu Miyazaki-Anzai et al. PLoS One
- Bile Acid Receptor TGR5 Agonism Induces NO Production and Reduces Monocyte Adhesion in Vascular Endothelial Cells
- (2013) Taiki Kida et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis
- (2013) Andrew Paul DeFilippis et al. ATHEROSCLEROSIS
- Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis
- (2013) Priya Handa et al. HEPATOLOGY
- Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells
- (2012) Divya P. Kumar et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Ceramide-Centric View of Insulin Resistance
- (2012) Jose A. Chavez et al. Cell Metabolism
- 2-Phenoxy-nicotinamides are Potent Agonists at the Bile Acid Receptor GPBAR1 (TGR5)
- (2012) Rainer E. Martin et al. ChemMedChem
- Activation of the Farnesoid X Receptor Induces Hepatic Expression and Secretion of Fibroblast Growth Factor 21
- (2012) Holly A. Cyphert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dual actions of fibroblast growth factor 19 on lipid metabolism
- (2012) Xinle Wu et al. JOURNAL OF LIPID RESEARCH
- Design, Synthesis, and Antidiabetic Activity of 4-Phenoxynicotinamide and 4-Phenoxypyrimidine-5-carboxamide Derivatives as Potent and Orally Efficacious TGR5 Agonists
- (2012) Hongliang Duan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
- (2012) Anna C. Calkin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Farnesoid X Receptor Agonist for the Treatment of Liver and Metabolic Disorders: Focus on 6-ethyl-CDCA
- (2011) S. Fiorucci et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
- (2011) Zeneng Wang et al. NATURE
- FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
- (2011) S. Kir et al. SCIENCE
- The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance
- (2010) Tim C. M. A. Schreuder et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- A Role of the Bile Salt Receptor FXR in Atherosclerosis
- (2010) Jurre Hageman et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain
- (2010) Verena Keitel et al. GLIA
- Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
- (2010) Luca Valenti et al. HEPATOLOGY
- Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice
- (2010) Galya Vassileva et al. JOURNAL OF ENDOCRINOLOGY
- Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
- (2010) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
- (2010) Klementina Fon Tacer et al. MOLECULAR ENDOCRINOLOGY
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- The Bile Acid Sensor FXR Protects against Dyslipidemia and Aortic Plaques Development Induced by the HIV Protease Inhibitor Ritonavir in Mice
- (2010) Andrea Mencarelli et al. PLoS One
- A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia
- (2009) Mark J. Evans et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders
- (2009) Verena Keitel et al. HEPATOLOGY
- Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
- (2009) Sushant Bhatnagar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glucose stimulates cholesterol 7α-hydroxylase gene transcription in human hepatocytes
- (2009) Tiangang Li et al. JOURNAL OF LIPID RESEARCH
- Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism
- (2009) Mary-Elizabeth Patti et al. Obesity
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
- (2009) E. Fabbrini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bile acid-activated receptors in the treatment of dyslipidemia and related disorders
- (2009) Stefano Fiorucci et al. PROGRESS IN LIPID RESEARCH
- Antiatherosclerotic effect of farnesoid X receptor
- (2008) Andrea Mencarelli et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Expression and function of the bile acid receptor TGR5 in Kupffer cells
- (2008) Verena Keitel et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Selective versus Total Insulin Resistance: A Pathogenic Paradox
- (2008) Michael S. Brown et al. Cell Metabolism
- Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects
- (2008) Kevin M. Korenblat et al. GASTROENTEROLOGY
- Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expression
- (2008) Kwang-Hoon Song et al. HEPATOLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
- Endocrine and paracrine role of bile acids
- (2008) Verena Keitel et al. WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started